EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-subtype FIV vaccines



Multi-subtype FIV vaccines



Official Gazette of the United States Patent & Trademark Office Patents 1248(1), July 3



The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. Methods for vaccinating cats with the subject vaccine compositions are also described. Cats vaccinated according to the methods and compositions of the subject invention exhibit protective humoral and cellular immune responses to FIV when challenged with homologous or heterologous strains of FIV. The subject invention also pertains to novel feline cell lines that are susceptible to infection by FIV and their methods of use.

(PDF 0-2 workdays service: $29.90)

Accession: 035349601

Download citation: RISBibTeXText



Related references

Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years. Human Vaccines & Immunotherapeutics 9(10): 2049-2059, 2014

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines. Vaccine 27(42): 5885-5895, 2009

The development of HIV-1 subtype C vaccines for Southern Africa. Iubmb Life 53(4-5): 207-208, 2002

Designing HIV-1 subtype C vaccines for South Africa. South African Journal of Science 96(6): 318-324, June, 2000

Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1. FEMS Immunology & Medical Microbiology 29(2): 123-127, October, 2000

Development of vaccines for HIV-1. Relevance of subtype-specific cellular immunity. Medicina 70(6): 543-554, 2011

New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges. Biodrugs 25(5): 285-298, 2012

Novel human immunodeficiency virus type 1 subtype C Gag and Pol DNA vaccines for future clinical evaluation. Journal of Medical Primatology 32(4-5): 291, August, 2003

Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines. Vaccine 25(26): 4949-4959, 2007

DNA Vaccines against H5 subtype of Avian influenza virus delivered by attenuated Salmonella and their immunogenicity in mice. Weishengwu Xuebao 44(2): 157-161, April, 2004

DNA vaccines against H5 subtype of avian influenza virus delivered by attenuated Salmonella spp. and their immunogenicity in mice. Animal Biotechnology Bulletin 9(1): 410-417, 2004

Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines. Vaccine 24(15): 2755-2763, 2006

Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines. Vaccine 33(9): 1129-1134, 2015

Enhancement effects of chicken interleukin-2 on immune responses of H5 subtype avian influenzavirus vaccines. Journal of Zhejiang University Agriculture and Life Sciences 31(6): 797-801, 2005